PAHC Overview

Phibro Animal Health Corporation is a diversified developer, manufacturer and marketer of a range of animal health and mineral nutrition products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Its segments include Animal Health, Mineral Nutrition and Performance Products. The Animal Health segment develops, manufactures and markets antibacterials which inhibit the growth of pathogenic bacteria that cause infections in animals. The Mineral Nutrition segment manufactures and markets formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.

Wall Street analysts forecast PAHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PAHC is47.50 USD with a low forecast of 45.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Phibro Animal Health Corp revenue for the last quarter amounts to 383.54M USD, increased 10.27

Phibro Animal Health Corp. EPS for the last quarter amounts to 0.59 USD, increased 15.69

Phibro Animal Health Corp (PAHC) has 2475 emplpoyees as of June 21 2026.

Today PAHC has the market capitalization of 1.29B USD.